カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

がん早期発見の世界市場2022：大腸がん、肝臓がん、肺がん、その他

◆英語タイトル：Global Cancer Early Detection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO17271 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：102 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

がん早期発見市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のがん早期発見の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

がん早期発見市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・大腸がん、肝臓がん、肺がん、その他

用途別セグメントは次のように区分されます。
・病院、医療センター、その他

世界のがん早期発見市場の主要な市場プレーヤーは以下のとおりです。
・Exact Sciences、Grail、Genetron Health、New Horizon Health、Burning Rock、Berry Oncology、Shanghai Kunyuan Biotechnology、Oncognostic、Epigenomics、Abbott、Qiagen、iStat Biomedical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、がん早期発見製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要ながん早期発見メーカーの企業概要、2019年～2022年までのがん早期発見の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要ながん早期発見メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別がん早期発見の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのがん早期発見の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのがん早期発見市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびがん早期発見の産業チェーンを掲載しています。
・第13、14、15章では、がん早期発見の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- がん早期発見の概要
- 種類別分析（2017年vs2021年vs2028年）：大腸がん、肝臓がん、肺がん、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、医療センター、その他
- 世界のがん早期発見市場規模・予測
- 世界のがん早期発見生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Exact Sciences、Grail、Genetron Health、New Horizon Health、Burning Rock、Berry Oncology、Shanghai Kunyuan Biotechnology、Oncognostic、Epigenomics、Abbott、Qiagen、iStat Biomedical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：大腸がん、肝臓がん、肺がん、その他
・用途別分析2017年-2028年：病院、医療センター、その他
・がん早期発見の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・がん早期発見のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・がん早期発見のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・がん早期発見の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・がん早期発見の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Cancer Early Detection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Early Detection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Cancer Early Detection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Colorectal Cancer segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cancer Early Detection include Exact Sciences, Grail, Genetron Health, New Horizon Health, and Burning Rock, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Early Detection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Market segment by Application can be divided into
Hospital
Medical Center
Other
The key market players for global Cancer Early Detection market are listed below:
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Early Detection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Early Detection, with price, sales, revenue and global market share of Cancer Early Detection from 2019 to 2022.
Chapter 3, the Cancer Early Detection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Early Detection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Early Detection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Early Detection.
Chapter 13, 14, and 15, to describe Cancer Early Detection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Cancer Early Detection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Early Detection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Early Detection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Global Cancer Early Detection Market Size & Forecast
1.4.1 Global Cancer Early Detection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cancer Early Detection Sales in Volume (2017-2028)
1.4.3 Global Cancer Early Detection Price (2017-2028)
1.5 Global Cancer Early Detection Production Capacity Analysis
1.5.1 Global Cancer Early Detection Total Production Capacity (2017-2028)
1.5.2 Global Cancer Early Detection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Early Detection Market Drivers
1.6.2 Cancer Early Detection Market Restraints
1.6.3 Cancer Early Detection Trends Analysis
2 Manufacturers Profiles
2.1 Exact Sciences
2.1.1 Exact Sciences Details
2.1.2 Exact Sciences Major Business
2.1.3 Exact Sciences Cancer Early Detection Product and Services
2.1.4 Exact Sciences Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grail
2.2.1 Grail Details
2.2.2 Grail Major Business
2.2.3 Grail Cancer Early Detection Product and Services
2.2.4 Grail Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genetron Health
2.3.1 Genetron Health Details
2.3.2 Genetron Health Major Business
2.3.3 Genetron Health Cancer Early Detection Product and Services
2.3.4 Genetron Health Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 New Horizon Health
2.4.1 New Horizon Health Details
2.4.2 New Horizon Health Major Business
2.4.3 New Horizon Health Cancer Early Detection Product and Services
2.4.4 New Horizon Health Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Burning Rock
2.5.1 Burning Rock Details
2.5.2 Burning Rock Major Business
2.5.3 Burning Rock Cancer Early Detection Product and Services
2.5.4 Burning Rock Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Berry Oncology
2.6.1 Berry Oncology Details
2.6.2 Berry Oncology Major Business
2.6.3 Berry Oncology Cancer Early Detection Product and Services
2.6.4 Berry Oncology Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shanghai Kunyuan Biotechnology
2.7.1 Shanghai Kunyuan Biotechnology Details
2.7.2 Shanghai Kunyuan Biotechnology Major Business
2.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection Product and Services
2.7.4 Shanghai Kunyuan Biotechnology Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Oncognostic
2.8.1 Oncognostic Details
2.8.2 Oncognostic Major Business
2.8.3 Oncognostic Cancer Early Detection Product and Services
2.8.4 Oncognostic Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Epigenomics
2.9.1 Epigenomics Details
2.9.2 Epigenomics Major Business
2.9.3 Epigenomics Cancer Early Detection Product and Services
2.9.4 Epigenomics Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business
2.10.3 Abbott Cancer Early Detection Product and Services
2.10.4 Abbott Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Qiagen
2.11.1 Qiagen Details
2.11.2 Qiagen Major Business
2.11.3 Qiagen Cancer Early Detection Product and Services
2.11.4 Qiagen Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 iStat Biomedical
2.12.1 iStat Biomedical Details
2.12.2 iStat Biomedical Major Business
2.12.3 iStat Biomedical Cancer Early Detection Product and Services
2.12.4 iStat Biomedical Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cancer Early Detection Breakdown Data by Manufacturer
3.1 Global Cancer Early Detection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cancer Early Detection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cancer Early Detection
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Early Detection Manufacturer Market Share in 2021
3.4.2 Top 6 Cancer Early Detection Manufacturer Market Share in 2021
3.5 Global Cancer Early Detection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cancer Early Detection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cancer Early Detection Market Size by Region
4.1.1 Global Cancer Early Detection Sales in Volume by Region (2017-2028)
4.1.2 Global Cancer Early Detection Revenue by Region (2017-2028)
4.2 North America Cancer Early Detection Revenue (2017-2028)
4.3 Europe Cancer Early Detection Revenue (2017-2028)
4.4 Asia-Pacific Cancer Early Detection Revenue (2017-2028)
4.5 South America Cancer Early Detection Revenue (2017-2028)
4.6 Middle East and Africa Cancer Early Detection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cancer Early Detection Sales in Volume by Type (2017-2028)
5.2 Global Cancer Early Detection Revenue by Type (2017-2028)
5.3 Global Cancer Early Detection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cancer Early Detection Sales in Volume by Application (2017-2028)
6.2 Global Cancer Early Detection Revenue by Application (2017-2028)
6.3 Global Cancer Early Detection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cancer Early Detection Sales by Type (2017-2028)
7.2 North America Cancer Early Detection Sales by Application (2017-2028)
7.3 North America Cancer Early Detection Market Size by Country
7.3.1 North America Cancer Early Detection Sales in Volume by Country (2017-2028)
7.3.2 North America Cancer Early Detection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cancer Early Detection Sales by Type (2017-2028)
8.2 Europe Cancer Early Detection Sales by Application (2017-2028)
8.3 Europe Cancer Early Detection Market Size by Country
8.3.1 Europe Cancer Early Detection Sales in Volume by Country (2017-2028)
8.3.2 Europe Cancer Early Detection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cancer Early Detection Sales by Type (2017-2028)
9.2 Asia-Pacific Cancer Early Detection Sales by Application (2017-2028)
9.3 Asia-Pacific Cancer Early Detection Market Size by Region
9.3.1 Asia-Pacific Cancer Early Detection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cancer Early Detection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cancer Early Detection Sales by Type (2017-2028)
10.2 South America Cancer Early Detection Sales by Application (2017-2028)
10.3 South America Cancer Early Detection Market Size by Country
10.3.1 South America Cancer Early Detection Sales in Volume by Country (2017-2028)
10.3.2 South America Cancer Early Detection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cancer Early Detection Sales by Type (2017-2028)
11.2 Middle East & Africa Cancer Early Detection Sales by Application (2017-2028)
11.3 Middle East & Africa Cancer Early Detection Market Size by Country
11.3.1 Middle East & Africa Cancer Early Detection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cancer Early Detection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cancer Early Detection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cancer Early Detection
12.3 Cancer Early Detection Production Process
12.4 Cancer Early Detection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cancer Early Detection Typical Distributors
13.3 Cancer Early Detection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ がん早期発見の世界市場2022：大腸がん、肝臓がん、肺がん、その他(Global Cancer Early Detection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

がん早期発見の世界市場2022：大腸がん、肝臓がん、肺がん、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp